1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Dahiyat, B.I. Mayo, S.L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking US Science SCIEAS 0038 0036-8075 278 82 87 10.1126/science.278.5335.82 9311930 De novo protein design: fully automated sequence selection. 1997 10.2210/pdb1fsd/pdb pdb_00001fsd 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 3497.037 FULL SEQUENCE DESIGN 1 OF BETA BETA ALPHA MOTIF 1 man polymer no no QQYTAKIKGRTFRNEKELRDFIEKFKGR QQYTAKIKGRTFRNEKELRDFIEKFKGR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n sample 32630 synthetic construct database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1997-11-12 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1997-06-09 REL REL NO RESTRAINT VIOLATIONS GREATER THAN 0.3 ANGSTROMS 100 41 NOESY DQF-COSY TOCSY 5.0 280 K STANDARD X-PLOR REFINEMENT PROTOCOLS WERE USED WITH A FINAL REPEL RADIUS OF 0.8. HYBRID DISTANCE GEOMETRY-SIMULATED ANNEALING BRUNGER refinement X-PLOR 3.1 structure solution X-PLOR 600 Varian UNITYPLUS GLN 1 n 1 GLN 1 A GLN 2 n 2 GLN 2 A TYR 3 n 3 TYR 3 A THR 4 n 4 THR 4 A ALA 5 n 5 ALA 5 A LYS 6 n 6 LYS 6 A ILE 7 n 7 ILE 7 A LYS 8 n 8 LYS 8 A GLY 9 n 9 GLY 9 A ARG 10 n 10 ARG 10 A THR 11 n 11 THR 11 A PHE 12 n 12 PHE 12 A ARG 13 n 13 ARG 13 A ASN 14 n 14 ASN 14 A GLU 15 n 15 GLU 15 A LYS 16 n 16 LYS 16 A GLU 17 n 17 GLU 17 A LEU 18 n 18 LEU 18 A ARG 19 n 19 ARG 19 A ASP 20 n 20 ASP 20 A PHE 21 n 21 PHE 21 A ILE 22 n 22 ILE 22 A GLU 23 n 23 GLU 23 A LYS 24 n 24 LYS 24 A PHE 25 n 25 PHE 25 A LYS 26 n 26 LYS 26 A GLY 27 n 27 GLY 27 A ARG 28 n 28 ARG 28 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 27 A A OD1 H ASN GLU 14 17 1.60 1 A GLN 2 -65.31 -79.47 1 A ALA 5 -61.86 80.40 1 A ILE 7 -51.76 -94.66 2 A GLN 2 -174.54 96.92 2 A ALA 5 -58.36 88.46 2 A ILE 7 -52.26 -93.56 2 A LYS 26 -90.72 58.43 3 A GLN 2 -174.66 96.51 3 A ALA 5 -62.53 81.04 3 A ILE 7 -47.05 -95.41 4 A GLN 2 -174.34 94.79 4 A ALA 5 -62.35 83.61 4 A ILE 7 -50.97 -93.59 4 A PHE 25 -140.40 40.20 4 A LYS 26 -91.18 57.68 5 A GLN 2 -76.97 -81.15 5 A ALA 5 -47.79 96.56 5 A ILE 7 -52.92 -94.97 5 A PHE 25 -97.72 -76.61 5 A LYS 26 174.81 -35.88 6 A GLN 2 -76.96 -80.96 6 A ALA 5 -59.71 87.38 6 A LYS 6 -92.27 55.85 6 A ILE 7 -48.64 -93.77 6 A PHE 25 -123.16 -86.21 7 A GLN 2 -102.04 -87.26 7 A ALA 5 -60.21 86.04 7 A ILE 7 -106.78 -77.43 7 A ARG 10 -151.46 89.53 8 A GLN 2 -110.61 -79.86 8 A ALA 5 -59.81 87.35 8 A ILE 7 -54.83 -89.98 8 A PHE 25 -98.72 30.53 9 A GLN 2 -178.80 100.69 9 A ALA 5 -58.05 87.90 9 A ILE 7 -54.05 -87.71 9 A PHE 21 -90.60 -60.37 9 A PHE 25 -102.51 -76.60 9 A LYS 26 176.94 -36.59 10 A GLN 2 -175.08 96.01 10 A ALA 5 -49.84 92.90 10 A LYS 6 -98.53 47.86 10 A ILE 7 -42.41 -95.23 10 A ARG 10 -160.22 110.15 11 A GLN 2 -80.26 -88.68 11 A LYS 6 -116.26 64.19 11 A ILE 7 -50.55 -93.44 12 A GLN 2 -116.96 -82.67 12 A ALA 5 -62.17 81.78 12 A ILE 7 -50.50 -88.19 13 A GLN 2 -177.00 101.47 13 A ALA 5 -59.28 92.03 13 A LYS 6 -67.82 90.95 13 A ILE 7 -57.62 -81.27 13 A ARG 10 -165.22 98.48 14 A GLN 2 -94.41 -85.28 14 A ALA 5 -45.91 94.73 14 A ILE 7 -48.45 -94.60 15 A GLN 2 -126.83 -82.78 15 A ALA 5 -51.67 176.74 15 A ILE 7 -51.00 -93.08 16 A GLN 2 -135.32 -80.79 16 A ALA 5 -58.06 96.90 16 A PHE 25 -141.02 39.55 16 A LYS 26 -91.83 57.61 17 A GLN 2 -103.29 -79.26 17 A ALA 5 -66.83 72.96 17 A LYS 6 -67.45 84.58 17 A ILE 7 -51.08 -91.53 17 A PHE 25 -133.67 -83.66 18 A GLN 2 -94.45 -80.48 18 A ALA 5 -58.27 177.66 18 A ILE 7 -54.97 -80.25 19 A GLN 2 -97.28 -79.10 19 A ALA 5 -59.31 86.77 19 A ILE 7 -48.35 -92.55 20 A GLN 2 -122.44 -88.49 20 A ALA 5 -45.61 93.90 20 A LYS 6 -95.98 53.75 20 A ILE 7 -44.45 -95.10 21 A GLN 2 -110.67 -84.83 21 A LYS 6 -111.81 78.11 21 A ILE 7 -51.49 -86.65 22 A GLN 2 -125.02 -65.36 22 A ALA 5 -58.95 89.78 22 A ILE 7 -57.06 -82.50 23 A GLN 2 -178.31 99.34 23 A ALA 5 -49.73 92.99 23 A LYS 6 -97.93 48.37 23 A ILE 7 -42.10 -94.41 24 A GLN 2 -79.30 -84.52 24 A ALA 5 -49.30 106.44 24 A ILE 7 -52.23 -95.68 24 A ARG 10 -173.46 139.90 25 A GLN 2 -126.00 -81.12 25 A ALA 5 -57.33 96.07 25 A ILE 7 -117.35 -80.71 25 A PHE 25 -127.28 -84.62 26 A ALA 5 -65.44 75.03 26 A ILE 7 -46.68 -94.36 27 A GLN 2 -133.86 -100.05 27 A ALA 5 -46.08 94.75 27 A LYS 6 -96.31 55.13 27 A ILE 7 -44.18 -95.64 28 A GLN 2 -120.36 -84.40 28 A ALA 5 -56.61 90.32 28 A ILE 7 -53.75 -97.06 29 A GLN 2 -125.25 -101.48 29 A ALA 5 -54.19 92.92 29 A ILE 7 -50.40 -93.51 30 A GLN 2 61.00 97.16 30 A ALA 5 -59.21 88.22 30 A ILE 7 -50.68 -94.11 31 A GLN 2 -86.63 -86.78 31 A ILE 7 -53.48 -98.22 32 A GLN 2 -88.33 -79.46 32 A ALA 5 -61.28 86.69 32 A ILE 7 -57.87 -90.72 33 A GLN 2 60.74 96.82 33 A ALA 5 -57.57 88.96 33 A ILE 7 -51.31 -96.37 34 A GLN 2 -61.27 -81.06 34 A ALA 5 -61.83 85.97 34 A ILE 7 -53.35 -88.94 34 A LYS 26 -90.88 58.21 35 A GLN 2 -127.71 -92.48 35 A ALA 5 -49.05 173.46 35 A LYS 6 -150.87 61.01 35 A ILE 7 -51.57 -94.34 35 A PHE 25 -133.38 -84.41 36 A GLN 2 -69.51 -85.63 36 A ALA 5 -52.76 109.36 36 A ILE 7 -49.66 -93.87 37 A GLN 2 -104.56 -88.98 37 A ILE 7 -51.73 -94.30 38 A GLN 2 -64.94 -80.09 38 A ALA 5 -64.08 77.26 38 A ILE 7 -47.39 -93.23 39 A GLN 2 60.42 94.69 39 A TYR 3 -108.13 48.73 39 A ALA 5 -53.24 92.96 39 A ILE 7 -55.09 -96.78 39 A ARG 10 -166.44 84.62 39 A PHE 25 -99.04 -76.19 39 A LYS 26 178.60 -36.53 40 A GLN 2 -106.45 -82.01 40 A ALA 5 -46.97 93.72 40 A ILE 7 -48.35 -89.51 41 A GLN 2 -103.09 -79.60 41 A ALA 5 -57.66 90.26 41 A ILE 7 -49.17 -94.62 41 A LYS 26 -92.33 58.06 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 FULL SEQUENCE DESIGN 1 (FSD-1) OF BETA BETA ALPHA MOTIF, NMR, 41 STRUCTURES 1 Y N A GLU 15 A GLU 15 HELX_P A PHE 25 A PHE 25 1 1 11 hydrog A ASN 14 A OD1 ASN 14 1_555 A GLU 17 A N GLU 17 1_555 NOVEL SEQUENCE NOVEL SEQUENCE, COMPUTATIONAL DESIGN 1FSD PDB 1 1FSD 1 28 1FSD 1 28 1FSD A 1 1 28 1 P 1